Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GO TEST FINALE gout remission strategy trial
2024-511111-13-01Phase 4Completed
- Sponsor
- Sint Maartenskliniek
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of allopurinol, benzbromarone and febuxostat in gout (2 arms), sponsored by Sint Maartenskliniek. Primary endpoint: Remission status over last 6 months of follow-up. Started Jul 2024; status: completed.
02
Drugs
allopurinolbenzbromaronefebuxostat
03
Conditions
gout
Beyond the preview
Go deeper on 2024-511111-13-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511111-13-01.